Pharmaceuticals

Rising Prevalence Of Chronic Diseases Propels Growth In The Peptide Therapeutics Market Is Supporting Development Across The Peptide Therapeutics Market

May 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Size Of The Peptide Therapeutics Market Progress Through 2030?

The peptide therapeutics market size has experienced rapid growth in recent years. It is projected to expand from $49.21 billion in 2025 to $54.62 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.0%. The expansion observed historically is attributable to the early adoption of peptide drugs, advancements in peptide synthesis techniques, a rising incidence of chronic and rare diseases, progress in pharmacology and biochemistry, and the proliferation of contract research organizations.

The peptide therapeutics market is projected to experience substantial expansion in the coming years, with its valuation set to reach $83.57 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.2%. This growth during the forecast period is attributable to several factors, including the emergence of personalized medicine, heightened investment in peptide-based therapeutics, the integration of artificial intelligence in drug discovery, the broadening of biologics manufacturing capabilities, and the expansion of healthcare solutions in emerging markets. Furthermore, major trends anticipated in this period encompass the development of targeted peptide drugs, innovations in peptide drug delivery, the rise of multi-functional peptide therapeutics, progress in natural peptide extraction and synthesis, and the increasing use of combination therapies with peptides.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp

Which Strategic Drivers Are Supporting The Peptide Therapeutics Market Development?

The growing incidence of chronic diseases is anticipated to propel the peptide therapeutics market. Chronic ailments are persistent conditions that are often beyond cure, though they can sometimes be managed and treated. The rise in chronic diseases is attributed to factors like increased tobacco product consumption, inadequate nutrition, a sedentary lifestyle, excessive alcohol intake, and other contributing elements. Peptide therapeutics play a role in both the prevention and treatment of specific chronic illnesses. For instance, data from January 2023, released by the US-based National Library of Medicine, projected that the number of individuals in the US aged 50 and above with at least one chronic condition would escalate by 99.5%, amounting to 142.66 million, by the year 2050. Consequently, the increasing prevalence of chronic diseases is expected to drive the peptide therapeutics market during the forecast period.

How Is The Peptide Therapeutics Market Distributed Across Key Segments?

The peptide therapeutics market covered in this report is segmented –

1) By Type: Generic, Branded

2) By Route of Administration: Parenteral, Mucosal, Oral, Transdermal

3) By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications

Subsegments:

1) By Generic: Generic Peptide Drugs, Biosimilars

2) By Branded: Innovative Peptide Drugs, Patent-Protected Peptides

Which Trends Are Influencing The Expansion Of The Peptide Therapeutics Market?

Major companies operating in the peptide therapeutics market are concentrating on introducing advanced solutions, such as the cell culture process, to gain a competitive edge. The cell culture process involves cultivating cells outside their natural environment, under controlled conditions, which includes isolating cells of interest from living tissue and subsequently maintaining them. For instance, in June 2023, Evonik Industries AG, a German-based specialty chemicals company, launched cQrex KC. This cQrex KC is a next-generation peptide for biopharma applications, specifically designed for the cell culture process utilized in the manufacture of biological drugs. It enables cell culture process developers to optimize cystine supply and increase cell culture productivity. Furthermore, cQrex KC supports the development of vaccines, viral vectors, and cell therapies.

Which Companies Are Engaged In The Peptide Therapeutics Market Environment?

Major companies operating in the peptide therapeutics market are Pfizer Inc., Jhonson & Jhonson, Abbvie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk AS, Teva Pharmaceuticals Industries Ltd., Bachem Holding AG, PolyPeptide Laboratories BV, Arcus Biosciences Inc., Pepscan Therapeutics, Peptech Inc., Peptide Logic Inc., SELLAS Life Sciences Group, Ever Neuro Pharma GmbH, Zealand Pharma AG, PepGen Inc., Pepticom S.A., Peptide Technologies Corporation, SynPeptide Inc., Peptimmune Inc., Merck & Co Inc.

Access The Complete Peptide Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Which Region Leads The Peptide Therapeutics Market By Size?

North America was the largest region in the peptide therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Peptide Therapeutics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp

Browse Through More Reports Similar to the Global Peptide Therapeutics Market 2026, By The Business Research Company

Peptide Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Peptide Synthesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-synthesis-global-market-report

Peptide Based Metabolic Disorders Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-based-metabolic-disorders-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795